Effects of MEK/PI3K dual inhibition or EGFR/MET dual inhibition on cell viability, apoptosis, cell cycle distribution in human EGFR-TKI resistant NSCLC cell lines with different genetic backgrounds. Here, MET is linked to non-small cell lung carcinoma.